48,470
edits
Difference between revisions of "Sertoli cell tumour"
Jump to navigation
Jump to search
no edit summary
| Line 67: | Line 67: | ||
==IHC== | ==IHC== | ||
*Alpha-inhibin +ve. ( | *Alpha-inhibin +ve (~95% of cases<ref name=pmid17721194/>). | ||
*Calretiin +ve (~55% of cases<ref name=pmid17721194/>). | |||
Others: | |||
*WT-1 +ve.<ref name=pmid17721194>{{Cite journal | last1 = Zhao | first1 = C. | last2 = Bratthauer | first2 = GL. | last3 = Barner | first3 = R. | last4 = Vang | first4 = R. | title = Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. | journal = Am J Surg Pathol | volume = 31 | issue = 9 | pages = 1378-86 | month = Sep | year = 2007 | doi = 10.1097/PAS.0b013e3180339961 | PMID = 17721194 }}</ref> | |||
==See also== | ==See also== | ||